Search Results - "Wemeau, L."

Refine Results
  1. 1

    2013 European Thyroid Association Guidelines for the Diagnosis and Treatment of Thyrotropin-Secreting Pituitary Tumors by Beck-Peccoz, P., Lania, A., Beckers, A., Chatterjee, K., Wemeau, J.-L.

    Published in European thyroid journal (01-06-2013)
    “…Hyperthyroidism is mainly due to autoimmune thyroid disorders or toxic goiter, and very rarely to the presence of thyrotropin (TSH)-secreting pituitary…”
    Get full text
    Journal Article
  2. 2

    Beneficial Effects of Propylthiouracil plus l-Thyroxine Treatment in a Patient with a Mutation in MCT8 by Wémeau, J. L., Pigeyre, M., Proust-Lemoine, E., d'Herbomez, M., Gottrand, F., Jansen, J., Visser, T. J., Ladsous, M.

    “…Context: Mutations of the monocarboxylate transporter 8 (MCT8) gene determine a distinct X-linked phenotype of severe psychomotor retardation and consistently…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Iodine 131 in the treatment of large goiters by Béron, A., Wémeau, J.-L.

    “…The treatment of large, complicated goiters with iodine 131 constitutes an interesting alternative to surgery. It is minimally invasive, safe, and effective in…”
    Get full text
    Journal Article
  5. 5

    Long-term effects of pulmonary rehabilitation on daily life physical activity of patients with stage IV sarcoidosis: A randomized controlled trial by Wallaert, B., Kyheng, M., Labreuche, J., Stelianides, S., Wemeau, L., Grosbois, J.M.

    Published in Respiratory medicine and research (01-03-2020)
    “…Pulmonary rehabilitation (PR) is known to improve exercise tolerance, mood, and quality of life in patients with chronic respiratory diseases. The aim of this…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Fertility and Obstetrical Complications in Women with LMNA-Related Familial Partial Lipodystrophy by Vantyghem, M. C., Vincent-Desplanques, D., Defrance-Faivre, F., Capeau, J., Fermon, C., Valat, A. S., Lascols, O., Hecart, A. C., Pigny, P., Delemer, B., Vigouroux, C., Wemeau, J. L.

    “…Objective: Familial partial lipodystrophy due to LMNA (lamin A/C) mutations is a rare disorder characterized by a selective loss of adipose tissue and insulin…”
    Get full text
    Journal Article
  10. 10

    Advances in diagnostic practices affect thyroid cancer incidence in France by Leenhardt, L, Bernier, MO, Boin-Pineau, MH, Conte Devolx, B, Marechaud, R, Niccoli-Sire, P, Nocaudie, M, Orgiazzi, J, Schlumberger, M, Wemeau, JL, Cherie-Challine, L, De Vathaire, F

    Published in European journal of endocrinology (01-02-2004)
    “…OBJECTIVE: To analyse trends in diagnostic practices of thyroid diseases and to relate them to the increase in thyroid cancer incidence in France over time…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Six-minute stepper test to assess effort intolerance in interstitial lung diseases by Delourme, J, Stervinou-Wemeau, L, Salleron, J, Grosbois, J M, Wallaert, B

    “…The six-minute stepper test (6MST) is a new test for evaluating exercise tolerance. Unlike the six-minute walk test (6MWT) it can be carried out in a limited…”
    Get full text
    Journal Article
  14. 14

    Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma? by Cardot-Bauters, C., Leteurtre, E., Leclerc, L., Vantyghem, M.-C., Do cao, C., Wemeau, J.-L., D'Herbomez, M., Carnaille, B., Barbu, V., Pinson, S., Pigny, P.

    Published in Clinical endocrinology (Oxford) (01-09-2008)
    “…Summary Objective  The RET (rearranged during transfection) proto‐oncogene G691S variant is over‐represented in the germline of patients with sporadic…”
    Get full text
    Journal Article
  15. 15

    Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome by CORTET, B, CORTET, C, BLANCKAERT, F, D'HERBOMEZ, M, MARCHANDISE, X, WEMEAU, J.-L, DECOULX, M, DEWAILLY, D

    Published in Osteoporosis international (01-02-2001)
    “…Quantitative ultrasound (QUS) of bone is a valuable tool in the assessment of postmenopausal osteoporosis. QUS and new markers of bone turnover have been…”
    Get full text
    Journal Article
  16. 16

    Treatment of carcinoid syndrome : A prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance by O'TOOLE, D, DUCREUX, M, BOMMELAER, G, WEMEAU, J.-L, BOUCHE, O, CATUS, F, BLUMBERG, J, RUSZNIEWSKI, P

    Published in Cancer (15-02-2000)
    “…The somatostatin analogues lanreotide and octreotide have previously been shown to be effective in controlling flushing and diarrhea in patients with carcinoid…”
    Get full text
    Journal Article
  17. 17

    Hypercalcitonemia revealing a somatostatinoma by Do Cao, C, Mekinian, A, Ladsous, M, Aubert, S, D’Herbomez, M, Pattou, F, Bourdelle-Hego, M.-F, Wémeau, J.-L

    Published in Annales d'endocrinologie (01-12-2010)
    “…Résumé Les somatostatinomes sont des tumeurs très rares, développées aux dépens de cellules endocrines duodénales ou pancréatiques. En général bien…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism by Vantyghem, M. C., Faivre-Defrance, F., Marcelli-Tourvieille, S., Fermon, C., Evrard, A., Bourdelle-Hego, M. F., Vigouroux, C., Defebvre, L., Delemer, B., Wemeau, J. L.

    Published in Clinical endocrinology (Oxford) (01-08-2007)
    “…Summary Objective  To describe new data about the wide phenotypic variability of diseases due to mutations in the lamin A/C gene (LMNA). Design  We report a…”
    Get full text
    Journal Article